BioSpace News Archive

AstraZeneca Canada announced that Health Canada has approved the expanded use of Symbicort® Turbuhaler® for the treatment of mild persistent asthma in patients 12 years and older.

The products under development will be sold across all Latin America, targeting Peru, Mexico, Paraguay, Bolivia and Ecuador in a first phase and gradually entering Chile, Colombia, Panama, Costa Rica, Argentina and Brazil over the next few years.

Canadian stem-cell start-up names commercialization expert Dr. Jennifer Moody as Chief Operating Officer ahead of first-in-human trials for innovative liver disease treatments

After a series of large-scale food safety problems almost a decade ago, Congress passed the U.S. Food and Drug Administration Food Safety Modernization Act, or FSMA, to shift our food safety system from one that focused primarily on responding to problems to a system that prevents them from happening in the first place.

Helsinn, the Swiss pharmaceutical group focused on building quality cancer care products, today announces two further abstracts have been accepted for oral presentations at the European Organization for Research and Treatment of Cancer (EORTC) Cutaneous Lymphoma Meeting 2019.

Almac Diagnostic Services, a member of the Almac Group, will launch the complete version of claraT at the ESMO Congress in Barcelona on 27th September.

Applied BioMath (www.appliedbiomath.com), the industry-leader in applying systems pharmacology and mechanistic modeling, simulation, and analysis to de-risk drug research and development, is proud to welcome Joshuaine Grant as Senior Principal Scientist.

CivaTech Oncology’s new device, CivaDerm™ has received FDA clearance. CivaDerm™ is a temporary radiation therapy product designed for intraoperative or surface radiation to treat skin cancer and other lesions.

The College of Healthcare Information Management Executives is pleased to announce that Grady Health System has earned 2019 CHIME HealthCare’s Most Wired recognition.

Betty Diamond, MD, director of the Institute of Molecular Medicine, and her colleagues at The Feinstein Institutes for Medical Research, revealed new insight into pro-inflammatory macrophages and their relation to autoimmune diseases, as published in the journal Proceedings of the National Academy of Sciences of the US.